Overview

Opsin Receptors in Melasma

Status:
Completed
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
Melasma is a hyperpigmentation disorder that is probably exacerbated by visible light. Opsin receptors (OPN 1, 2, 3, 4 y 5) were described in the skin, being capable of activating melanogenesis induced by visible light. The aim of this study was to evaluate the expression of OPN in melasma skin and its changes following treatment with UV-Vis filter and 0.05% retinoic acid for 12 weeks.
Phase:
N/A
Details
Lead Sponsor:
Universidad Autonoma de San Luis Potosí
Collaborator:
Hospital Central "Dr. Ignacio Morones Prieto"
Treatments:
Tretinoin